Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use

被引:4
作者
Subramanian, Sreedhar [1 ]
Asher, Rebecca [2 ]
Weston, William [1 ]
Rimmer, Michael [1 ]
McConville, Adam [1 ]
Malin, Alex [1 ]
Jackson, Richard [2 ]
Collins, Paul [1 ]
Probert, Chris [3 ]
Dibb, Martyn [1 ]
Rhodes, Jonathan M. [3 ]
机构
[1] Royal Liverpool Univ Hosp, Dept Gastroenterol, Prescot St, Liverpool L7 8XP, Merseyside, England
[2] Canc Res UK, Liverpool Canc Trials Unit, Liverpool, Merseyside, England
[3] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England
关键词
inflammatory bowel disease; Crohn's disease; ulcerative colitis; patient-reported outcome; IBD-10; Harvey-Bradshaw index; simple clinical colitis activity index; QUALITY-OF-LIFE; CROHNS-DISEASE; ULCERATIVE-COLITIS; FECAL CALPROTECTIN; ACTIVITY INDEXES; QUESTIONNAIRE; THERAPY; FATIGUE; ADULTS; TOOL;
D O I
10.1097/MIB.0000000000000803
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background:Various physician- and patient-reported instruments exist for quantification of disease activity in inflammatory bowel diseases (IBD) but none are widely used in routine clinical practice. A simple patient-reported outcome measure might help inform clinical decision making. We evaluated a patient-reported 0 to 10 score of IBD activity (IBD-10) by correlation with conventional multicomponent activity indices.Methods:A single-center prospective cross-sectional study was conducted in ambulant patients with IBD. Patients were asked to verbally rate the control of Crohn's disease (CD) or ulcerative colitis (UC) on a numerical scale from 0 to 10, with 10 indicating perfect control. Disease activity was assessed using Harvey-Bradshaw index for CD and simple clinical colitis activity index for UC.Results:A total of 405 patients were included, of whom 209 (52%) had CD and 196 (48%) had UC. The median age was 41 (interquartile range, 27-55) years. IBD-10 correlated well with Harvey-Bradshaw Index (r(s) = -0.69, P < 0.001) and simple clinical colitis activity index (r(s) = -0.79, P < 0.001). An IBD-10 score of 7 predicted remission (defined by Harvey-Bradshaw index/simple clinical colitis activity index) with 90% sensitivity (95% confidence interval [CI], 86-94) and 75% specificity (95% CI, 67-82). The discriminatory ability of IBD-10 for remission was better for UC (area under the receiver operating characteristic curve, 0.93; 95% CI, 0.89-0.97) than for CD (area under the receiver operating characteristic curve, 0.86; 95% CI, 0.81-0.91; P = 0.035). An IBD-10 score of <7 correlated with treatment escalation.Conclusions:The IBD-10 score correlates well with more complex clinical activity indices. Correlation was less strong for CD than for UC, possibly reflecting a weaker link in CD between stool frequency and the patient perspective of disease activity. The IBD-10 score could readily be used in routine clinical practice.
引用
收藏
页码:1902 / 1907
页数:6
相关论文
共 25 条
  • [1] Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease
    Allen, P. B.
    Kamm, M. A.
    Peyrin-Biroulet, L.
    Studd, C.
    Mc Dowell, C.
    Allen, B. C. M.
    Connell, W. R.
    De Cruz, P. P.
    Bell, S. J.
    Elliot, R. P.
    Brown, S.
    Desmond, P. V.
    Lemann, M.
    Colombel, J-F.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) : 438 - 444
  • [2] Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study
    Bassi, A
    Dodd, S
    Williamson, P
    Bodger, K
    [J]. GUT, 2004, 53 (10) : 1471 - 1478
  • [3] Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-Control questionnaire
    Bodger, Keith
    Ormerod, Clare
    Shackcloth, Daniela
    Harrison, Melanie
    [J]. GUT, 2014, 63 (07) : 1092 - 1102
  • [4] Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
    Boon, Gudula J. A. M.
    Day, Andrew S.
    Mulder, Chris J.
    Gearry, Richard B.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (40) : 11469 - 11480
  • [5] Development and psychometric testing of inflammatory bowel disease fatigue (IBD-F) patient self-assessment scale
    Czuber-Dochan, Wladyslawa
    Norton, Christine
    Bassett, Paul
    Berliner, Stuart
    Bredin, Francesca
    Darvell, Marcia
    Forbes, Alastair
    Gay, Martin
    Nathan, Indira
    Ream, Emma
    Terry, Helen
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 (11) : 1398 - 1406
  • [6] Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study
    Danese, Silvio
    Rudzinski, Janusz
    Brandt, Wolfgang
    Dupas, Jean-Louis
    Peyrin-Biroulet, Laurent
    Bouhnik, Yoram
    Kleczkowski, Dariusz
    Uebel, Peter
    Lukas, Milan
    Knutsson, Mikael
    Erlandsson, Fredrik
    Hansen, Mark Berner
    Keshav, Satish
    [J]. GUT, 2015, 64 (02) : 243 - 249
  • [7] Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
    Dhaliwal, A.
    Zeino, Z.
    Tomkins, C.
    Cheung, M.
    Nwokolo, C.
    Smith, S.
    Harmston, C.
    Arasaradnam, R. P.
    [J]. FRONTLINE GASTROENTEROLOGY, 2015, 6 (01) : 14 - 19
  • [8] Gutacker N, 2015, J R SOC MED
  • [9] HARVEY RF, 1980, LANCET, V1, P514
  • [10] Irvine EJ, 1996, AM J GASTROENTEROL, V91, P1571